Digitalis Ventures

www.digitalisventures.com

VCMatch tracks Digitalis Ventures as an investor focused on Biotech, Digital Health, and Medtech companies, Pre-Seed and Seed rounds, and United States, Global, and Switzerland markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Biotech, Digital Health, Medtech

Geography

United States, Global, and Switzerland

Investment Thesis

Digitalis Ventures focuses on financing, building, and scaling companies that address clearly identified unmet needs in health. The firm combines a multidisciplinary team with deep technical, financial, and domain expertise to back early-stage life sciences, health technology & services, and animal health companies, supporting them through multiple rounds of financing and operational growth. Digitalis emphasizes rigorous problem identification — tying science and technology to economic, policy, and social context — and aims to create enduring enterprises that improve health at scale.

Is Digitalis Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Digitalis Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Digital Health, Medtech, and Pharma, especially across United States, Global, and Switzerland.

Focus statement

Digitalis invests in biotechnology companies leveraging breakthrough science to improve human health and in technology-enabled solutions that improve access to care and outcomes while reducing costs; through Companion Funds (in partnership with Mars Petcare) they also invest in companies leveraging science, technology, and design to improve animal health.

Value Add

Multidisciplinary team combining deep technical, financial, and domain expertise across human and animal health.
Part of the broader Digitalis Group (Digitalis Research and Digitalis Commons), enabling applied research and public-interest technology work alongside VC activity.
Active thought leadership and publishing ('Notes') used to identify and articulate unmet needs as a core part of deal origination and thesis development.
Dedicated Companion Funds and an explicit commercial partnership with Mars Petcare, providing founders access to large operational assets (e.g., 'More than 70,000 Associates... caring for more than 25 million pets each year across 2,500+ clinics and labs').
Offers founder programs / accelerator partnerships (e.g., Leap Venture Studio with Michelsen Found Animals and R/GA Ventures) for earliest-stage companies.
Emphasis on long-term networks with entrepreneurs, research institutions, and co-investors to support companies through multiple financing rounds.